Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

29/07/2021 09:00

Grande áreaBiológicas / Saúde / Exatas e da Terra / Engenharias

Tipo de oportunidadeBolsa

Objetivo: the purpose of this funding opportunity announcement (FOA) is twofold: 1). to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2). to understand the underlying mechanisms of their action(s), and variability in responses to these interventions.

Inscrições: até 08 de setembro de 2021

Local: Estados Unidos

Mais informações no site.

Tags: BolsaEstados UnidosExterior